๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

4011 POSTER Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-a or the combination of temsirolimus + interferon-a

โœ Scribed by P. de Souza; K. Maart; A. Laurell; R.E. Hawkins; A. Berkenblit; L. Galand; A. Thiele; A. Strahs; J. Feingold; G. Hudes

Book ID
118625921
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
85 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Interferon-ฮฑ-2a with or without 13-cis r
Interferon-ฮฑ-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma : Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)
โœ Sophie D. Fossรฅ; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin